<p>Having just been appointed chief operating officer of contract manufacturing services organization (MSA) Lykan Bioscience, Patrick Lucy reflects on an illustrious career in the biopharma space and the parallels of today's cell and gene therapy landscape with that of monoclonal antibodies 30 years ago. </p>

Having just been appointed chief operating officer of contract manufacturing services organization (MSA) Lykan Bioscience, Patrick Lucy reflects on an illustrious career in the biopharma space and the parallels of today's cell and gene therapy landscape with that of monoclonal antibodies 30 years ago.

<p>Having just been appointed chief operating officer of contract manufacturing services organization (MSA) Lykan Bioscience, Patrick Lucy reflects on an illustrious career in the biopharma space and the parallels of today's cell and gene therapy landscape with that of monoclonal antibodies 30 years ago.&nbsp;</p>

From mAbs to cell and gene therapies with Patrick Lucy

From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head.

www.bioprocessinsider.com

Business

Science

Life Sciences

From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head. www.bioprocessinsider.com

Share From mAbs to cell and gene therapies with Patrick Lucy

Sign up to save your podcasts

From mAbs to cell and gene therapies with Patrick Lucy

From mAbs to cell and gene therapies with Patrick Lucy